TXTM TXTM

ProText Mobility (PK) Stock Price

0.00605
0.00 (0.0%)
0.00605
Volume 0.00
Bid Price 0.002
Ask Price 0.0074
News -
Day High

Low
0.0007

52 Week Range

High
0.02

Day Low
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
ProText Mobility Inc (PK) TXTM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.00605 07:31:42
Open Price Low Price High Price Close Price Prev Close
0.00605
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0007 - 0.02
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00605 USD

Period:

Draw Mode:

ProText Mobility Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 47.38M 7.83B - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
337.27k $ - - - -

more financials information »

ProText Mobility (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TXTM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01140.0130.00580.0081211148,433,129-0.00535-46.93%
1 Month0.00190.020.00160.0097102373,353,2330.00415218.42%
3 Months0.00140.020.00120.0079203155,805,8710.00465332.14%
6 Months0.00120.020.00090.006467791,103,7570.00485404.17%
1 Year0.00170.020.00070.0041777127,272,6960.00435255.88%
3 Years0.00020.020.00010.003305870,865,6040.005852,925.0%
5 Years0.00080.020.00010.00279353,412,1310.00525656.25%

ProText Mobility (PK) Description

Protext Pharma, Inc. (F.K.A. Protext Mobility), operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (PTY) LTD. and Cannabis Biosciences, Inc. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Plandai Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Phytofare Catechin Complex, has been clinically shown to have 10x greater bioavailability over generic catechin extracts. Cannabis Biosciences has developed a proprietary processing and extraction technology that utilizes live plant for producing a full-profile cannabis extract, that contains the precursor acid form of THC (THC-A and THC-B) found in live cannabis plant. The Company has conducted in investigations in SA which has shown that the Cannabis Biosciences extraction process, using live plant material and low temperatures to extract the phyto-chemicals, leaves the acid forms of THC intact.
Your Recent History
USOTC
TXTM
ProText Mo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220707 11:57:21